| Literature DB >> 21931285 |
Marina Petrova1, Ruslan Muhamadejev, Brigita Vigante, Brigita Cekavicus, Aiva Plotniece, Gunars Duburs, Edvards Liepinsh.
Abstract
The diastereotopy of the methylene protons at positions 2 and 6 in 1,4-dihydropiridine derivatives with various substituents has been investigated. NMR spectroscopy and quantum chemistry calculations show that the CH···O intramolecular hydrogen bond is one of the factors amplifying the chemical shift differences in the 1H-NMR spectra.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21931285 PMCID: PMC6264772 DOI: 10.3390/molecules16098041
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Characterization of compounds 1–5.
| Comp. | R1 | R2 | R3 | R4 | Yield,% | Reference |
|---|---|---|---|---|---|---|
|
| Me | Et | Br | H | 59 | |
|
| Ph | Et | Br | Me | 88 | |
|
| PhCF3-o | Et | Br | H | 76 | |
|
| PhOCHF2-o | (CH2)2OC3H7- | Br | H | 61 | |
|
| COOMe | Et | Cl | H | 87 | |
|
| Ph | Et | Br | H | 47 | [ |
|
| PhOCHF2-o | Me | Br | H | 86 | [ |
|
| Ph | C12H25 | Br | H | 72 | [ |
|
| PhOCHF2-o | Me | Br | Me | 89 | |
|
| Me | Et | Py+Br− | H | 63 | |
|
| Ph | Et | Py+Br− | Me | 66 | |
|
| PhCF3-o | Et | Py+Br− | H | 93 | |
|
| PhOCHF2-o | (CH2)2OC3H7- | Py+Br− | H | 74 | |
|
| COOMe | Et | Py+Cl− | H | 91 | |
|
| Ph | Et | Py+Br− | H | 63 | [ |
|
| PhOCHF2-o | Me | Py+Br− | H | 64 | [ |
|
| PhOCHF2-o | Me | Py+Br− | Me | 84 | |
|
| Ph | C10H21 | Py+Br− | H | 63 | [ |
|
| Ph | C12H25 | Py+Br− | H | 82 | [ |
|
| Ph | C14H29 | Py+Br− | H | 35 | [ |
|
| Ph | C16H33 | Py+Br− | H | 33 | [ |
|
| Ph | C12H25 | Py+Br− | Me | 38 | [ |
|
| Ph | 20 | [ | |||
|
| PhOCHF2-o | 33 | [ | |||
|
| Ph | 50 | [ | |||
|
| PhOCHF2-o | 60 | [ |
Scheme 1Synthesis of compounds 1 and 2.
Scheme 2Synthesis of compounds 1e, 2e.
1H-NMR data of compounds 1–5.
| Comp. | Solvent | δNH | δHB | 1J(C,HB) | δHA | 1J(C,HA) | 2J(H,H) |
|---|---|---|---|---|---|---|---|
|
| CDCl3 | 6.35 | 4.89 | 159 | 4.51 | 157 | 11.5 |
| DMSO | 9.44 | 4.69 | 4.40 | 9.6 | |||
|
| CDCl3 | 4.96 | 4.82 | 11.0 | |||
| DMSO | 5.17 | 4.87 | 11.3 | ||||
|
| CDCl3 | 6.49 | 4.81 | 159 | 4.66 | 157 | 11.6 |
| DMSO | 9.67 | 4.61 | 158 | 4.56 | 157 | 9.9 | |
|
| CDCl3 | 6.55 | 4.86 | 4.57 | 11.8 | ||
| DMSO | 9.62 | 4.67 | 4.53 | 9.7 | |||
|
| CDCl3 | 7.37 | 5.19 | 160 | 4.74 | 158 | 14.6 |
| DMSO | 9.78 | 4.93 | 158 | 4.48 | 156 | 11.1 | |
|
| CDCl3 | 6.45 | 4.91 | 159 | 4.63 | 156.4 | 11.8 |
| DMSO | 9.58 | 4.67 | 160 | 4.57 | 158.7 | 9.6 | |
|
| CDCl3 | 6.56 | 4.86 | 4.62 | 11.3 | ||
| DMSO | 9.65 | 4.62 | 4.59 | 9.7 | |||
|
| CDCl3 | 6.45 | 4.92 | 158 | 4.63 | 156 | 11.5 |
| DMSO | 9.62 | 4.68 | 159 | 4.59 | 157 | 9.7 | |
|
| CDCl3 | 4.91 | 4.84 | 11.0 | |||
| DMSO | 5.18 | 4.85 | 11.4 | ||||
|
| CDCl3 | 10.88 | 6.28 | 5.76 | 14.1 | ||
| DMSO | 10.10 | 5.99 | 5.49 | 15.0 | |||
|
| CDCl3 | 6.82 | 152.1 | 6.59 | 146.3 | 15.6 | |
| DMSO | 6.45 | 152.2 | 5.77 | 146.2 | 16.0 | ||
|
| CDCl3 | 10.98 | 6.35 | 153.1 | 5.97 | 147.1 | 13.6 |
| DMSO | 10.48 | 5.97 | 151.1 | 5.66 | 149.1 | 15.1 | |
|
| CDCl3 | 10.80 | 6.16 | 6.11 | 14.1 | ||
| DMSO | 10.15 | 5.90 | 150.1 | 5.62 | 149.2 | 14.9 | |
|
| CDCl3 | 10.31 | 6.30 | 6.06 | 14.1 | ||
| DMSO | 10.20 | 5.97 | 5.64 | 15.6 | |||
|
| CDCl3 | 10.92 | 6.38 | 150.6 | 5.92 | 146.5 | 13.6 |
| DMSO | 10.34 | 6.08 | 151.9 | 5.63 | 146.4 | 15.3 | |
|
| CDCl3 | 10.88 | 6.24 | 6.10 | 13.7 | ||
| DMSO | 10.31 | 5.94 | 5.46 | 14.9 | |||
|
| CDCl3 | 6.84 | 6.62 | 15.8 | |||
| DMSO | 6.39 | 5.77 | 16.2 | ||||
|
| CDCl3 | 10.96 | 6.40 | 150.7 | 5.89 | 146.5 | 13.9 |
| DMSO | 10.21 | 6.08 | 151.1 | 5.56 | 145.4 | 15.1 | |
|
| CDCl3 | 10.95 | 6.40 | 151.4 | 5.89 | 146.3 | 13.9 |
| DMSO | 10.12 | 6.07 | 152.4 | 5.53 | 146.3 | 15.0 | |
|
| CDCl3 | 10.92 | 6.32 | 150.1 | 5.86 | 146.2 | 13.8 |
| DMSO | 10.28 | 6.08 | 152.1 | 5.56 | 146.4 | 15.1 | |
|
| CDCl3 | 10.96 | 6.40 | 148.3 | 5.89 | 146.2 | 13.9 |
| DMSO | 10.12 | 6.07 | 5.53 | 15.2 | |||
|
| CDCl3 | 6.73 | 152.5 | 6.56 | 150.2 | 16.1 | |
| DMSO | 6.48 | 152.5 | 5.78 | 147.5 | 16.5 | ||
|
| CDCl3 | 8.30 | 4.52 | and | 4.47 | 16.7 | |
| DMSO | 9.74 | 4.84 | and | 4.74 | 16.5 | ||
|
| CDCl3 | 6.42 | 4.69 | and | 4.65 | 16.4 | |
|
| DMSO | 9.91 | 4.72 | and | 4.65 | 16.0 | |
|
| DMSO | 9.97 | 4.64 | and | 4.60 | 16.2 |
Comparison of H-bond parameters in model compounds 1f, 1b and 2b, 2f and 3b.
| Compound | C2(CH···O) | C6(CH···O) | C2 pyr(CH···O) | C6 pyr(CH···O) |
|---|---|---|---|---|
|
| 2.508 Å, | 2.511 Å, | - | - |
| (86.6°) | (86.5°) | |||
| 2.376 Å, | 2.374 Å, | |||
| (93.6°) | (93.7°) | |||
|
| 2.032 Å, | 2.073 Å, | - | - |
| (131.5°) | (126.0°) | |||
|
| 2.329 Å, | 2.168 Å, | 2.629 Å, | 2.152 Å, |
| (99.6°) | (117.7°) | (89.7°) | (137.3°) | |
|
| 2.254 Å, | 2.198 Å, | 2.544 Å, | 2.913 Å, |
| (103.9°) | (107.7°) | (94.0°) | (87.5°) | |
|
| 2.341 Å, | 2.366 Å, | 2.591 Å, | 2.849 Å, |
| (98.914°) | (96.979°) | (90.362°) | (82.121°) |
Figure 1The calculated optimal conformations in compounds 1f, 1b and 2f, 2b.
Figure 2Slice of 1H-NMR NOESY spectrum for compound 3b. More intense NOE is registered between NH and HA, showing preferable orientation toward the NH.
Figure 31H-NMR spectral data of D2O solutions of compound 3b at 25 °C.